Covid-19

Traws Pharma's Oral COVID Drug Shows Comparable Results To Paxlovid

FDA's Prasad Cites Alleged Child COVID Shot Deaths in Push for Stricter Rules

Moderna's COVID-19 Vaccine Update Boosts Antibodies 16-Fold, Data Shows

FDA's Prasad Cites Alleged Child COVID Shot Deaths in Push for Stricter Rules

Moderna's COVID-19 Vaccine Update Boosts Antibodies 16-Fold, Data Shows

Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults

Moderna Expands Cost-Cutting Program By Up To $1.7 Billion, FDA Approval For Flu/COVID-19 Combo Shot Delayed Into 2026

Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults

Moderna Expands Cost-Cutting Program By Up To $1.7 Billion, FDA Approval For Flu/COVID-19 Combo Shot Delayed Into 2026

Trump's New COVID Website Takes Aim At WHO, Fauci, And Biden Over Pandemic Response, Calls Out China Lab Leak Theory

Novavax Covid Vaccine Shows Milder Side Effects Than Pfizer-BioNTech's Shot: Study

Covid-19 Recent News

Pfizer Shares Are Down Today: What's Going On?

Pfizer shares are trading lower Wednesday after a Wall Street Journal report revealed that U.S. prosecutors are investigating a claim about the timing of Pfizer's COVID-19 vaccine announcement.

'Black Swan' Hedge Fund Posts 4,000% Profits During COVID-19 Market Crash: Here's How

Universa Investments hedge fund, led by billionaire investor Mark Spitznagel, posted a 4,144% return in a single quarter during the COVID-19 market crash in early 2020. Here's a look at how he did it.

FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients

Invivyd's bid to expand Pemgarda's EUA for COVID-19 treatment was denied by the FDA. The company will share new data on pemivibart and VYD2311 soon.

Invivyd Touts Encouraging Data From COVID-19 Antibody Trial, Stock Jumps

Invivyd data shows strong potency and prolonged antibody levels in trials. Q4 Pemgarda revenue rose 48% to $13.8 million.

Robert Kennedy Jr. Faces Senate Confirmation Hearings As Bird Flu Concerns Grow: Caroline Kennedy Says Cousin 'Predator' Unfit For Office

Robert F. Kennedy, Jr. will begin Senate confirmation hearings on Wednesday as President Donald Trump's pick to lead the Department of Health and Human Services.

US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally

The Louisiana Department of Health on Monday reported the first human death in the U.S. related to the H5N1 bird flu virus. The CDC is also reporting high levels of acute respiratory illnesses nationwide.

Bird Flu Puts Teen In Critical Condition As Canada Reports First Human Case: What You Need To Know

Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective COVID-19 vaccines.

Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped

On Wednesday, Ark Invest, led by Cathie Wood, made significant trades in Moderna Inc. (NASDAQ:MRNA) and Square Inc. (NYSE:SQ). The Moderna Trade

Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology

Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle technology without permission in the development of its COVID-19 vaccines.

Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock

On Wednesday, Cathie Wood’s Ark Invest made significant trades involving Block Inc (NYSE:SQ) and Moderna Inc (NASDAQ:MRNA). The SQ Trade

Robinhood, Novavax, Phunware, Lucid Group, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

On Wednesday, major U.S. indices saw gains, with the Dow Jones Industrial Average climbing nearly 0.8% to 43,077.70.

Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table

On Thursday Oct 10, 2024 Cathie Wood-Led Ark Invest sold over $9 million worth of Moderna stock.

Alnylam's Concedes Its Patent Infringement Case Against Moderna's COVID-19 Vaccine

Alnylam Pharmaceuticals has conceded that Moderna's products do not infringe on its patents, as a court ruling determined. Both companies have agreed to dismiss the case without prejudice for possible future actions.

Gilead Sciences Recalls One Lot Of Its COVID-19 Treatment Due To Presence Of Glass Particles

Gilead Sciences has recalled one lot of its COVID-19 treatment, Veklury (remdesivir), due to glass particles found in vials. Gilead is notifying distributors to cease use and return the remaining vials.

Harris Hit Trump With Claim Of 'Worst Unemployment Since The Great Depression' During Debate, Here Is What The Economists Said

In their first debate for the 2024 election, Vice President Kamala Harris criticized former President Donald Trump for severe unemployment during his tenure, as well as his economic policies and handling of t

Cannabis Use Linked To Improved COVID-19 Outcomes, New Study Suggests

Explore how the latest study suggests cannabis use linked to improved COVID-19 outcomes, highlighting potential health benefits.

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Here's a look at five stocks that saw increased attention from Benzinga readers during the week and the reasons why.

Mark Zuckerberg's Admission Of Censorship A 'Beautiful Thing,' Says Vivek Ramaswamy: 'I Respect Him' For Admitting His Mistake

Americans To Access COVID-19 Test Kits For Free As US Government Restarts Free At-Home Program

US households can order free COVID-19 tests starting in late September as the government reopens the program ahead of the fall virus season.

FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot

The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including new formulas from Moderna and Pfizer/BioNTech. These vaccines, designed to match current variants and will be available soon.

FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch

The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.

Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows

A recent NIH study reveals no clear diagnostic test for Long Covid, highlighting ongoing challenges in identifying and treating the condition affecting millions of Americans. Researchers continue to explore more specialized testing.

Markets Experience Best And Worst Days Since 2022: What's Next In Wall Street's Rollercoaster Ride?

Volatility spiked due to weak jobs report, yen carry trade collapse, and recession fears. Investors brace for similar price action and macro uncertainties.